TEAMSS (Transforming Expanded Access to Maximize Support and Study) seeks to advance clinical care and translational research by improving patient access to experimental therapies. This federated, national consortium for Expanded Access interventions is a partnership led by the University of Michigan with Duke University, University of Rochester and University of Texas Southwestern
- American Journal of Bioethics
Here we further analyze the complexity and inherent unfairness of offering COVID-19 drugs via multiple clinical and research pathways. Using remdesivir as an example, we highlight the systemic biases that multiple pathways—both individually and as an overarching system—can engender for vulnerable patients.
- June 05, 2020
Since MICHR was awarded the Transforming Expanded Access to Maximize Support and Study (TEAMSS) grant two years ago, the consortium of universities involved in TEAMSS has worked to develop and test infrastructure, best practices, and reduce burdensome data collection for expanded access that will allow other academic medical centers to become more effective and efficient in supporting these requests.
- Journal of Clinical and Translational Science